News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Chinmay Jani: SCLC no longer left behind
Chinmay Jani/X
Apr 13, 2025, 16:17

Chinmay Jani: SCLC no longer left behind

Chinmay Jani, Clinical Fellow of Hematology and Oncology at the University of Miami, shared a post on X:

“SCLC no longer left behind!

The FOMO is slowly fading as novel therapies emerge across lines:

  • Consolidation durvalumab is now standard for LS-SCLC.
  • DLL3 BiTEs -Tarlatamab and ADCs (TROP2, SEZ6, B7-H3) in various lines.

Fantastic panel led by Lauren Averett Byers!”

Chinmay Jani: SCLC no longer left behind

More posts featuring Chinmay Jani.

cancer Chinmay Jani Lauren Averett Byers Lung cancer OncoDaily Oncology SCLC TexasLung25
Special Coverage
Science
Apr 14, 2025, 12:55
Jame Abraham: Educational Video as an Alternative to Pretest In-Person Genetic Counselling in Candidates for Cancer Genetic Testing
Cancer Types
Apr 14, 2025, 12:52
Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates
Blog
Apr 14, 2025, 12:44
E. Shyam P. Reddy: To grow, cancer tumors must hijack the immune system for their needs
Blog
Apr 14, 2025, 12:43
Mel Mann: Never found a donor and I still became HISTORY
Blog
Apr 14, 2025, 12:42
Anirban Maitra: The lineup for the summer 2025 Gordon Research Conferences on Pancreatic Diseases
Blog
Apr 14, 2025, 12:25
Yazan Madanat: Novel investigational therapies in lower-risk MDS
Dialogues
Apr 14, 2025, 12:23
Cancer Through My Eyes – Episode 9: Charles J Milrod
Blog
Apr 14, 2025, 12:16
Farina Arreguin: Sharing pediatric oncology experience in the management of germ cell tumors at AYAS
Blog
Apr 14, 2025, 12:16
The best and brightest cancer researchers were funded with $12M+ in 2024 - Conquer Cancer, the ASCO Foundation
Blog
Apr 14, 2025, 12:14
Amol Akhade: Important Sessions to Watch at ESMO Breast 2025 in Munich
Drugs
Apr 14, 2025, 11:48
Cathy Eng: Apixaban for the primary endpoint of cancer-related recurrent thrombosis
Blog
Apr 14, 2025, 11:40
Kim Stanbery: Celebrating 50 Years of Excellence in Oncology Nursing